Cargando…
Incidence of diabetes mellitus and neoplasia in Japanese short-statured children treated with growth hormone in the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS)
The primary goal of the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS) was to assess the safety and effectiveness of Humatrope(®), a GH preparation, in the treatment of pediatric patients with short stature. We report our findings in the GH-treated Japanese pediatric...
Autores principales: | Yokoya, Susumu, Hasegawa, Tomonobu, Ozono, Keiichi, Tanaka, Hiroyuki, Kanzaki, Susumu, Tanaka, Toshiaki, Chihara, Kazuo, Jia, Nan, Child, Christopher J., Ihara, Katsuichiro, Funai, Jumpei, Iwamoto, Noriyuki, Seino, Yoshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627224/ https://www.ncbi.nlm.nih.gov/pubmed/29026272 http://dx.doi.org/10.1297/cpe.26.229 |
Ejemplares similares
-
Responses to the Letter to the Editor “Does growth-hormone treatment affect
patients with and without a mitochondrial disorder differentially ?” (Vol. 27, No. 2, p.
107–108, 2018)
por: Yokoya, Susumu, et al.
Publicado: (2018) -
Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study
por: Cappa, M., et al.
Publicado: (2015) -
Efficacy and safety of growth hormone treatment in Japanese children with
small-for-gestational-age short stature in accordance with Japanese
guidelines
por: Yokoya, Susumu, et al.
Publicado: (2018) -
Inequalities in the assessment of childhood short stature
por: Davies, Justin H, et al.
Publicado: (2023) -
The long-term safety and effectiveness of growth hormone treatment in
Japanese children with short stature born small for gestational age
por: Horikawa, Reiko, et al.
Publicado: (2020)